Interaction of 5-HTT and HTR1A Gene Polymorphisms in Treatment Responses to Mirtazapine in Patients With Major Depressive Disorder
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chang, Hun Soo | - |
dc.contributor.author | Lee, Hwa-Young | - |
dc.contributor.author | Cha, Ji-Hyun | - |
dc.contributor.author | Won, Eun Soo | - |
dc.contributor.author | Ham, Byung-Joo | - |
dc.contributor.author | Kim, Bohye | - |
dc.contributor.author | Lee, Min-Soo | - |
dc.date.accessioned | 2021-09-05T06:22:52Z | - |
dc.date.available | 2021-09-05T06:22:52Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-08 | - |
dc.identifier.issn | 0271-0749 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97783 | - |
dc.description.abstract | We tested for the association of HTR1A and 5-HTT genetic polymorphisms with treatment response to mirtazapine and evaluated the interactive effect between the polymorphisms in 283 patients with major depressive disorder. Korean subjects with diagnosis of major depressive disorder using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Axis I disorders were recruited. Clinical symptoms were evaluated using the 17-item Hamilton Depression Rating (HAMD-17) Scale at baseline and after 1, 2, 4, 8, and 12 weeks of treatment with mirtazapine. The genetic association of 5-HTTLPR and HTR1A+272G>A with treatment response was analyzed. We found a significant association of the 12.12-repeat genotype of 5-HTT various number tandem repeat (VNTR) with a large percentage decline in HAMD-17 Scale score after 4, 8, and 12 weeks of treatment with mirtazapine. We also found that the frequency of the 12.12-repeat genotype was higher in responders than in non-responders at week 8. The HTR1A+272GG genotype was significantly associated with a large percentage decline in HAMD-17 Scale score at 4, 8, and 12 weeks, although the genotypic frequencies were comparable between responders and nonresponders during the study period. Patients with the 12.12-repeat 5-HTT VNTR and GG of HTR1A+272G>A showed the highest HAMD-17 Scale percentage reduction during the study period and a better treatment response status after 4 weeks. These results suggest that the interaction between HTR1A+272G>A and 5-HTT VNTR is involved in the response to mirtazapine treatment and that a combination of these may be a useful marker for predicting treatment response to mirtazapine. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.subject | TRANSPORTER PROMOTER POLYMORPHISM | - |
dc.subject | 5-HYDROXYTRYPTAMINE 1A RECEPTOR | - |
dc.subject | SEROTONIN TRANSPORTER | - |
dc.subject | ANTIDEPRESSANT RESPONSE | - |
dc.subject | THERAPEUTIC RESPONSE | - |
dc.subject | ASSOCIATION | - |
dc.subject | DORSAL | - |
dc.subject | PAROXETINE | - |
dc.subject | BINDING | - |
dc.subject | FLUVOXAMINE | - |
dc.title | Interaction of 5-HTT and HTR1A Gene Polymorphisms in Treatment Responses to Mirtazapine in Patients With Major Depressive Disorder | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ham, Byung-Joo | - |
dc.contributor.affiliatedAuthor | Lee, Min-Soo | - |
dc.identifier.doi | 10.1097/JCP.0000000000000143 | - |
dc.identifier.scopusid | 2-s2.0-84903752583 | - |
dc.identifier.wosid | 000338854700006 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, v.34, no.4, pp.446 - 454 | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | - |
dc.citation.title | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | - |
dc.citation.volume | 34 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 446 | - |
dc.citation.endPage | 454 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | TRANSPORTER PROMOTER POLYMORPHISM | - |
dc.subject.keywordPlus | 5-HYDROXYTRYPTAMINE 1A RECEPTOR | - |
dc.subject.keywordPlus | SEROTONIN TRANSPORTER | - |
dc.subject.keywordPlus | ANTIDEPRESSANT RESPONSE | - |
dc.subject.keywordPlus | THERAPEUTIC RESPONSE | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | DORSAL | - |
dc.subject.keywordPlus | PAROXETINE | - |
dc.subject.keywordPlus | BINDING | - |
dc.subject.keywordPlus | FLUVOXAMINE | - |
dc.subject.keywordAuthor | major depression | - |
dc.subject.keywordAuthor | serotonin transporter | - |
dc.subject.keywordAuthor | serotonin receptor 1A | - |
dc.subject.keywordAuthor | mirtazapine | - |
dc.subject.keywordAuthor | treatment response | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.